Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12084442 | Naphthyridinone derivatives for the treatment of a disease or disorder | Atwood Kim CHEUNG, Stefan Peukert, Heng GE, Yu Gai, Xingjuan CHANG | 2024-09-10 |
| 11845730 | 1,3-substituted cyclobutyl derivatives and uses thereof | Julien Papillon, Stefan Peukert, James J. Powers | 2023-12-19 |
| 9765067 | Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators | Christopher M. Adams, David B. Belanger, Doug Bevan, Takeru Ehara, Luciana Ferrara +6 more | 2017-09-19 |
| 8541432 | Heterobicyclic carboxamides as inhibitors for kinases | Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Fupeng Ma, Nello Mainolfi +4 more | 2013-09-24 |
| 8501756 | Heterobicyclic carboxamides as inhibitors for kinases | Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Fupeng Ma, Nello Mainolfi +4 more | 2013-08-06 |
| 8492393 | Heterobicyclic carboxamides as inhibitors for kinases | Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Fupeng Ma, Nello Mainolfi +4 more | 2013-07-23 |
| 8486954 | Heterobicyclic carboxamides as inhibitors for kinases | Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Fupeng Ma, Nello Mainolfi +4 more | 2013-07-16 |
| 8431584 | Heterobicyclic carboxamides as inhibitors for kinases | Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Fupeng Ma, Nello Mainolfi +4 more | 2013-04-30 |
| 8242125 | Heterobicyclic carboxamides as inhibitors for kinases | Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Fupeng Ma, Nello Mainolfi +4 more | 2012-08-14 |
| 7109196 | 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders | Yamin Wang, William Bullock, David Gunn, Qingjie Liu, Sidney Liang +5 more | 2006-09-19 |
| 6900205 | 1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders | Yamin Wang, William Bullock, David Gunn, Qingjie Liu, Sidney Liang +5 more | 2005-05-31 |